Page 86 - Read Online
P. 86
Annibali et al. Mini-invasive Surg 2022;6:12 https://dx.doi.org/10.20517/2574-1225.2021.101 Page 15 of 16
62. Mack MJ, Leon MB, Thourani VH, et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-
expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705. DOI PubMed
63. Popma JJ, Deeb GM, Yakubov SJ, et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-
expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15. DOI PubMed
64. Tarantini G, Nai Fovino L. Lifetime strategy of patients with aortic stenosis: the first cut is the deepest. JACC Cardiovasc Interv
2021;14:1727-30. DOI PubMed
65. Tarantini G, Nai Fovino L, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter
aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv 2020;13:e008972. DOI PubMed PMC
66. Bapat VN, Zaid S, Fukuhara S, et al; EXPLANT-TAVR Investigators. Surgical explantation after TAVR failure: Mid-term outcomes
from the EXPLANT-TAVR international registry. JACC Cardiovasc Interv 2021;14:1978-91. DOI PubMed
67. Fukuhara S, Brescia AA, Shiomi S, et al. Surgical explantation of transcatheter aortic bioprostheses: results and clinical implications. J
Thorac Cardiovasc Surg 2021;162:539-47.e1. DOI PubMed PMC
68. Percy ED, Harloff MT, Hirji S, et al. Nationally representative repeat transcatheter aortic valve replacement outcomes: report from the
centers for medicare and medicaid services. JACC Cardiovasc Interv 2021;14:1717-26. DOI PubMed
69. Hirji SA, Percy ED, McGurk S, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter
aortic valve replacement. J Am Coll Cardiol 2020;76:1848-59. DOI PubMed
70. Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am
Coll Cardiol 2020;75:1882-93. DOI PubMed
71. Attizzani GF, Ohno Y, Latib A, et al. Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: a
multicenter study. Int J Cardiol 2017;227:543-9. DOI PubMed
72. Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural
and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv 2016;9:e003930. DOI
PubMed
73. Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC
Cardiovasc Interv 2020;13:2542-55. DOI PubMed
74. Bleiziffer S, Simonato M, Webb JG, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic
valves. Eur Heart J 2020;41:2731-42. DOI PubMed
75. Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic
valves: an observational study. Lancet 2017;389:2383-92. DOI PubMed
76. Blanke P, Leipsic JA, Popma JJ, et al; Evolut Low Risk LTI Substudy Investigators. Bioprosthetic aortic valve leaflet thickening in the
evolut low risk sub-study. J Am Coll Cardiol 2020;75:2430-42. DOI PubMed
77. De Backer O, Dangas GD, Jilaihawi H, et al; GALILEO-4D Investigators. Reduced leaflet motion after transcatheter aortic-valve
replacement. N Engl J Med 2020;382:130-9. DOI PubMed
78. Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med
2015;373:2015-24. DOI PubMed
79. Dangas GD, Tijssen JGP, Wöhrle J, et al; GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve
replacement. N Engl J Med 2020;382:120-9. DOI PubMed
80. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without Clopidogrel after transcatheter aortic-valve implantation. N
Engl J Med 2020;382:1696-707. DOI PubMed
81. Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without Clopidogrel after transcatheter aortic-valve implantation. N Engl J
Med 2020;383:1447-57. DOI PubMed
82. Makkar RR, Blanke P, Leipsic J, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3
cardiac computed tomography substudy. J Am Coll Cardiol 2020;75:3003-15. DOI PubMed
83. Abdel-Wahab M, Simonato M, Latib A, et al. Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation. Circ
Cardiovasc Interv 2018;11:e006730. DOI PubMed
84. Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve
implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous
Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. Eur Heart J 2021;42:2265-9.
DOI PubMed
85. Jose J, Sulimov DS, El-Mawardy M, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement:
incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv 2017;10:686-97. DOI PubMed
86. Vahidkhah K, Javani S, Abbasi M, et al. Blood stasis on transcatheter valve leaflets and implications for valve-in-valve leaflet
thrombosis. Ann Thorac Surg 2017;104:751-9. DOI PubMed
87. Brown ML, Park SJ, Sundt TM, Schaff HV. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac
Cardiovasc Surg 2012;144:108-11. DOI PubMed
88. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve
implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129-38. DOI PubMed
89. Eitan A, Brinkmann C, Haselbach T, Witt J, Schofer J. Does valve in valve TAVR carry a higher risk for thromboembolic events
compared to native valve TAVR? Catheter Cardiovasc Interv 2020;95:1017-21. DOI PubMed
90. Macherey S, Meertens M, Mauri V, et al. Meta-analysis of stroke and mortality rates in patients undergoing valve-in-valve
transcatheter aortic valve replacement. J Am Heart Assoc 2021;10:e019512. DOI PubMed PMC